Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 6, 2006, Pages

  Khomenko, Tetyana ^b   Szabo, Sandor ^a   Deng, Xiaoming ^b   Jadus, Martin R ^b   Ishikawa, Hideki ^b   Osapay, Klara ^b   Sandor, Zsuzsa ^b   Chen, Longchuan ^b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Angiogenic growth factors; Cysteamine induced duodenal ulcer; Early growth response factor 1; Transcription regulation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; EARLY GROWTH RESPONSE FACTOR 1; ETHANOLAMINE; FIBROBLAST GROWTH FACTOR; MERCAPTAMINE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUODENUM MUCOSA; DUODENUM ULCER; FEMALE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; ULCEROGENESIS; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; DUODENAL ULCER; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION REGULATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; SUPPRESSION, GENETIC;

EID: 33646867425     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00078.2005     Document Type: Article

References (52)

1. Bae SK, Bae MH, Ahn MY, Son MJ, Lee YM, Bae MK, Lee OH, Park BC, and Kim KW. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res 59: 5989-5994, 1999.
2. Banks MF, Gerasimovskaya EV, Tucker DA, Frid MG, Carpenter TC, and Stenmark KR. Egr-1 antisense oligonucleotides inhibit hypoxia-induced proliferation of pulmonary artery adventitial fibroblasts. J Appl Physiol 98: 732-738, 2005.
3. Biesiada E, Razandi M, and Levin ER. Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation. J Biol Chem 271: 18576-18581, 1996.
4. Chao JC, Liu KY, Chen SH, Fang CL, and Tsao CW. Effect of oral epidermal growth factor on mucosal healing in rats with duodenal ulcer. World J Gastroenterol 9: 2261-2265, 2003.
5. Dieckgraefe BK and Weems DM. Epithelial injury induces Egr-1 and Fos expression by a pathway involving protein kinase C and ERK. Am J Physiol Gastrointest Liver Physiol 276: G322-G330, 1999.
6. Farivar AS, Mackinnon-Patterson BC, Barnes AD, McCourtie AS, and Mulligan MS. Cyclosporine modulates the response to hypoxia-reoxygenation in pulmonary artery endothelial cells. Ann Thorac Surg 79: 1010-1016, 2005.
7. Freston JW. Helicobacter pylori-negative peptic ulcers: frequency and implications for management. J Gastroenterol 35: 29-32, 2000.
8. Giampaolo C, Gray AT, Olshen RA, and Szabo S. Predicting chemically induced duodenal ulcer and adrenal necrosis with classification trees. Proc Natl Acad Sci USA 88: 6298-6302, 1991.
9. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, and Malaty HM. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116: 705-708, 1992.
10. Han SS, Chung ST, Robertson DA, Chelvarajan RL, and Bondada S. CpG oligodeoxynucleotides rescue BKS-2 immature B cell lymphoma from anti-IgM-mediated growth inhibition by up-regulation of egr-1. Int Immunol 11: 871-879, 1999.
11. Heiniger CD, Kostadinova RM, Rochat MK, Serra A, Ferrari P, Dick B, Frey BM, and Frey FJ. Hypoxia causes downregulation of 11β-hydroxysteroid dehydrogenase type 2 by induction of Egr-1. FASEB J 17: 917-919, 2003.
12. Hofer G, Grimmer C, Sukhatme VP, Sterzel RB, and Rupprecht HD. Transcription factor Egr-1 regulates glomerular mesangial cell proliferation. J Biol Chem 271: 28306-28310, 1996.
13. Huang RP and Adamson DA. A biological role for Egr-1 in cell survival following ultra-violet irradiation. Oncogene 10: 467-475, 1995.
14. Hunt RH. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori. Am J Gastroenterol 92: 36S-40S, 1997.
15. Iwai-Kanai E, Hasegawa K, Fujita M, Araki M, Yanazume T, Adachi S, and Sasayama S. Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J Cell Physiol 190: 54-62, 2002.
16. Jin N, Hatton N, Swartz DR, Xia X, Harrington MA, Larsen SH, and Rhoades RA. Hypoxia activates jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. Am J Respir Cell Mol Biol 23: 593-601, 2000.
17. Keeton AB, Bortoff KD, Bennett WL, Franklin JL, Venable DY, and Messina JL. Insulin-regulated expression of Egr-1 and Krox20: dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology 144: 5402-5410, 2003.
18. Khachigian LM, Lindner V, Williams AJ, and Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271: 1427-1431, 1996.
19. Khomenko T, Deng XM, Jadus MR, and Szabo S. Effect of cysteamine on redox-sensitive thiol-containing proteins in the duodenal mucosa. Biochem Biophys Res Commun 309: 910-916, 2003.
20. Khomenko T, Deng X, Sandor Z, Tarnawski AS, and Szabo S. Cysteamine alters redox state, HIF-1α transcriptional interactions and reduces duodenal mucosal oxygenation: novel insight into the mechanisms of duodenal ulceration. Biochem Biophys Res Commun 317: 121-127, 2004.
21. Khomenko T, Szabo S, Jadus MR, Yoshida M, Deng XM, Matsumoto H, and Florsheim W. The distribution of the transcription factors Egr-1 and Sp1 in nuclear and cytoplasmic fractions of duodenal mucosa after cysteamine (Abstract). Proc Soc Exp Biol Med 225: 166, 2000.
22. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M, and Esumi H. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276: 2292-2298, 2001.
23. Lemaire P, Revelant O, Bravo R, and Charnay P. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 85: 4691-4695, 1988.
24. Maas A, Grohe C, Kubisch C, Wollnik B, Vetter H, and Neyses L. Hormonal induction of an immediate-early gene response in myogenic cell lines - a paradigm for heart growth. Eur Heart J 16: 12-14, 1995.
25. Mason JC, Lidington EA, Ahmad SR, and Haskard DO. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am J Physiol Cell Physiol 282: C578-C587, 2002.
26. Mehrotra M, Krane SM, Walters K, and Pilbeam C. Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem 93: 741-752, 2004.
27. Midgley VC and Khachigian LM. Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1. J Biol Chem 279: 40289-40295, 2004.
28. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, and Clowes AW. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res 96: 172-179, 2005.
29. Nair VD, Yuen T, Olanow CW, and Sealfon SC. Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress. J Biol Chem 279: 27494-27501, 2004.
30. Peppel K, Zhang L, Orman ES, Hagen PO, Amalfitano A, Brian L, and Freedman NJ. Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovasc Res 65: 674-682, 2005.
31. Rupprecht HD, Hofer G, de Heer E, Sterzel RB, Faller G, and Schoecklmann HO. Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation. Kidney Int 51: 694-702, 1997.
32. Rupprecht HD, Sukhatme VP, Lacy J, Sterzel RB, and Coleman DL. PDGF-induced Egr-1 expression in rat mesangial cells is mediated through upstream serum response elements. Am J Physiol Renal Fluid Electrolyte Physiol 265: F351-F360, 1993.
33. Santiago FS, Atkins DG, and Khachigian LM. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGF1-A-dependent. Am J Pathol 155: 897-905, 1999.
34. Santiago FS, Lowe HC, Day FL, Chesterman CN, and Khachigian LM. Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am J Pathol 154: 937-944, 1999.
35. Santiago FS, Lowe HC, Kavurma MM, Chesterman CN, Baker A, Atkins DG, and Khachigian LM. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med 5: 1264-1269, 1999.
36. Schwachtgen JL, Houston P, Campbell C, Sukhatm VP, and Braddock M. Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase-1/2 mitogen-activated protein kinase pathway. J Clin Invest 101: 2540-2549, 1998.
37. Selye H and Szabo S. Experimental model for production of perforating duodenal ulcers by cysteamine in rats. Nature 224: 458-459, 1973.
38. Sonnenberg A and Everhart JE. Health impact of peptic ulcer in the United States. Am J Gastroenterol 92: 614-620, 1997.
39. Szabo S. Animal model of human disease. Duodenal ulcer disease. Animal model: cysteamine-induced acute and chronic ulcer in the rat. Am J Pathol 93: 273-276, 1978.
40. Szabo S, Deng X, Khomenko T, Yoshida M, Jadus MR, Sandor Z, Gombos Z, and Matsumoto H. Gene expression and gene therapy in experimental duodenal ulceration. J Physiol 95: 325-335, 2001.
41. Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, and Kato K. Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology 106: 1106-1111, 1994.
42. Szabo S, Levin E, Vincze A, Pedram A, Sandor ZS, and Jadus M. Endothelin release and expression of immediate early genes in the early stage of duodenal ulceration (Abstract). Gastroenterology 110: A140, 1996.
43. Szabo S and Pihan G. Development and significance of cysteamine and propionitrile models of duodenal ulcer. Chronobiol Int 4: 31-42, 1987.
44. Szabo S, Reynolds ES, and Unger SH. Structure-activity relations between alkyl nucleophilic chemicals causing duodenal ulcer and adrenocortical necrosis. J Pharmacol Exp Ther 223: 68-76, 1982.
45. Szabo S and Sandor Z. Basic fibroblast growth factor and PDGF in GI disease. In: Bailliere's Clinical Gastroenterology, edited by Goodlad RA and Wright NA. London: Saunders, 1996, p. 97-112.
46. Szabo S, Vincze A, Sandor Z, Jadus M, Gombos Z, Pedram A, Levin E, Hagar J, and Laquinto G. Vascular approach to gastroduodenal ulceration: new studies with endothelins and VEGF. Dig Dis Sci 43: 40S-45S, 1998.
47. Tarnawski A. Molecular mechanisms of ulcer healing. Drug News Perspect 13: 158-168, 2000.
48. Tran J, Master Z, Yu JL, Rak J, Dumont DJ, and Kerbel RS. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci USA 99: 4349-4354, 2002.
49. Troyer KL, Luetteke NC, Saxon ML, Qiu TH, Xian CJ, and Lee DC. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha. Gastroenterology 121: 68-78, 2001.
50. Vidal F, Aragones J, Arantzazu A, and de Landazuri MO. Upregulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1. Blood 95: 3387-3394, 2000.
51. Wagle A and Singh JP. Fibroblast growth factor protects nitric oxide-induced apoptosis in neuronal SHSY-5Y cells. J Pharmacol Exp Ther 295: 889-895, 2000.
52. Wilson E, Vives F, Collins T, and Ives HE. Strain-responsive region in the platelet-derived growth factor-A gene promoter. Hypertension 31: 170-175, 1998.